Log in to save to my catalogue

Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aure...

Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aure...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10579052

Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Treatment failure occurs in about 25% of patients with methicillin-susceptible
Staphylococcus

aureus
(MSSA) bacteremia. We assessed whether cloxacillin plus fosfomycin achieves better treatment success than cloxacillin alone in hospitalized adults with MSSA bacteremia. We conducted a multicenter, open-label, phase III–IV superiority r...

Alternative Titles

Full title

Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10579052

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10579052

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-023-02569-0

How to access this item